Fidelity Investments’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
AC
GS
VCM
CBU
Fidelity Investments's TMCI Position: Q1 2026 in Review
Fidelity Investments reduced its Treace Medical Concepts (TMCI) stake by 52% in Q1 2026, selling an estimated $107K and leaving 48,700 shares worth $65.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3993.
Fidelity Investments first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $19.2M in Q2 2021. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.
- Fidelity Investments held 48,700 shares of Treace Medical Concepts worth $65.3K as of Q1 2026.
- Fidelity Investments sold 53,750 Treace Medical Concepts shares in Q1 2026, an estimated $107K.
- Treace Medical Concepts made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3993 holding.
- Fidelity Investments first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
- Fidelity Investments's Treace Medical Concepts position peaked at $19.2M in Q2 2021.
- 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.